| |
| |
|
| Insider
Information: |
Mauro David J |
| Relationship: |
Chief Medical Officer |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
410,900 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,050,515 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
410,900 |
|
|
| Total
Value |
$2,050,515 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Advaxis Inc |
ADXS |
Chief Medical Officer |
2015-12-31 |
166,271 |
2014-10-20 |
0 |
Premium* |
|
|
Prelude Therapeutics Inc |
PRLD |
Chief Medical Officer |
2021-10-05 |
0 |
2021-04-07 |
0 |
Premium* |
|
|
Recursion Pharmaceuticals, Inc. |
RXRX |
Chief Medical Officer |
2024-02-09 |
244,629 |
2023-06-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RXRX |
Recursion Pharmaceuticals... |
Chief Medical Officer |
• – – |
2024-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
55,808 |
246,521 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Medical Officer |
• – – |
2024-02-09 |
4 |
D |
$10.09 |
$19,090 |
D/D |
(1,892) |
244,629 |
0 |
- |
|
| RXRX |
Recursion Pharmaceuticals... |
Chief Medical Officer |
• – – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
190,713 |
190,713 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-10-05 |
4 |
AS |
$30.26 |
$464,350 |
D/D |
(15,000) |
0 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-10-05 |
4 |
OE |
$1.89 |
$28,350 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-09-07 |
4 |
OE |
$1.89 |
$28,350 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-09-07 |
4 |
AS |
$35.91 |
$550,283 |
D/D |
(15,000) |
0 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-08-05 |
4 |
AS |
$29.93 |
$466,394 |
D/D |
(15,000) |
0 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-08-05 |
4 |
OE |
$1.89 |
$28,350 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-07-06 |
4 |
AS |
$27.17 |
$412,107 |
D/D |
(15,000) |
0 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-07-06 |
4 |
OE |
$1.89 |
$28,350 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-06-07 |
4 |
AS |
$30.35 |
$486,622 |
D/D |
(15,000) |
0 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-06-07 |
4 |
OE |
$1.89 |
$28,350 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-05-05 |
4 |
AS |
$39.36 |
$602,092 |
D/D |
(15,000) |
0 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-05-05 |
4 |
OE |
$1.89 |
$28,350 |
D/D |
15,000 |
15,000 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-04-27 |
4 |
OE |
$1.89 |
$47,250 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-04-27 |
4 |
AS |
$34.66 |
$884,848 |
D/D |
(25,000) |
0 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-04-19 |
4 |
AS |
$30.82 |
$772,349 |
D/D |
(25,000) |
0 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-04-19 |
4 |
OE |
$1.89 |
$47,250 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-04-08 |
4 |
AS |
$37.04 |
$368,852 |
D/D |
(9,617) |
0 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-04-08 |
4 |
OE |
$1.89 |
$18,176 |
D/D |
9,617 |
9,617 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-04-07 |
4 |
OE |
$1.89 |
$29,074 |
D/D |
15,383 |
15,383 |
0 |
- |
|
| PRLD |
Prelude Therapeutics Inc |
Chief Medical Officer |
• – – |
2021-04-07 |
4 |
AS |
$39.03 |
$605,023 |
D/D |
(15,383) |
0 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Chief Medical Officer |
• – – |
2015-12-31 |
4 |
D |
$10.06 |
$412 |
D/D |
(41) |
166,271 |
0 |
- |
|
| ADXS |
Advaxis Inc |
Chief Medical Officer |
• – – |
2015-12-31 |
4 |
A |
$10.06 |
$1,962 |
D/D |
195 |
166,312 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
